Johnson & Johnson
JNJNYSEHealthcare● Active
$232.77
+$4.60(+2.02%)
Market Cap$560.3B
P/E Ratio—
52W High$251.71
52W Low$149.04
Johnson & Johnson（JNJ）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · JNJ · 截至 2026-06-08
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2023-01 | 2022-01 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $26.80B | $14.07B | $13.33B | $17.94B | $20.88B |
| Depreciation & Amort. | $7.50B | $7.34B | $7.49B | $6.97B | $7.39B |
| Stock-Based Comp. | $1.35B | $1.18B | $1.16B | $1.14B | $1.14B |
| Change in Working Capital | ($12.72B) | $1.84B | $2.51B | ($4.01B) | ($4.24B) |
| Net Cash from Operations | $24.53B | $24.27B | $22.79B | $21.19B | $23.41B |
| Investing Activities | |||||
| Capital Expenditure | ($4.83B) | ($4.42B) | ($4.54B) | ($4.01B) | ($3.65B) |
| Purchases of Investments | ($0.92B) | ($1.73B) | ($10.91B) | ($32.38B) | ($30.39B) |
| Sales of Investments | $1.66B | $2.46B | $19.39B | $41.61B | $25.01B |
| Net Cash from Investing | ($23.59B) | ($18.60B) | $0.88B | ($12.37B) | ($8.68B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($5.95B) | ($2.43B) | ($5.05B) | ($6.04B) | ($3.46B) |
| Dividends Paid | ($12.38B) | ($11.82B) | ($11.77B) | ($11.68B) | ($11.03B) |
| Debt Issued / Repaid | $9.64B | $10.05B | ($2.73B) | $7.45B | ($0.99B) |
| Net Cash from Financing | ($5.54B) | ($3.13B) | ($15.82B) | ($8.87B) | ($14.05B) |
| Free Cash Flow | |||||
| Free Cash Flow | $19.70B | $19.84B | $18.25B | $17.18B | $19.76B |
| FCF Margin %(computed) | 20.91% | 22.34% | 21.43% | 21.48% | 25.09% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Johnson & Johnson
关于Johnson & Johnson（JNJ）现金流量表
Johnson & Johnson 2025财年经营活动现金流$24.53B，自由现金流$19.70B（FCF利润率20.91%），资本支出($4.83B)。
常见问题
JNJ · 4 问Johnson & Johnson 2025财年自由现金流$19.70B，同比down0.7%。
JNJ free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08